Kingsview Wealth Management LLC Has $875,000 Stock Position in The Clorox Company (NYSE:CLX)

Kingsview Wealth Management LLC increased its stake in shares of The Clorox Company (NYSE:CLX – Get Rating) by 6.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,812 shares of the company’s stock after buying an additional 384 shares during the period. Kingsview Wealth Management LLC’s holdings in Clorox were worth $875,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. American Century Companies Inc. lifted its position in Clorox by 18.0% during the 1st quarter. American Century Companies Inc. now owns 8,320 shares of the company’s stock valued at $1,157,000 after purchasing an additional 1,269 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in Clorox by 6.8% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 16,465 shares of the company’s stock valued at $2,289,000 after purchasing an additional 1,044 shares during the period. Cibc World Market Inc. lifted its position in Clorox by 276.6% during the 1st quarter. Cibc World Market Inc. now owns 9,318 shares of the company’s stock valued at $1,295,000 after purchasing an additional 6,844 shares during the period. Dimensional Fund Advisors LP lifted its position in Clorox by 0.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 683,818 shares of the company’s stock valued at $95,073,000 after purchasing an additional 5,145 shares during the period. Finally, Blair William & Co. IL lifted its position in Clorox by 81.1% during the 1st quarter. Blair William & Co. IL now owns 24,525 shares of the company’s stock valued at $3,410,000 after purchasing an additional 10,981 shares during the period. Institutional investors and hedge funds own 79.12% of the company’s stock.

Clorox Price Performance

NYSE CLX opened at $153.79 on Wednesday. The business has a 50 day simple moving average of $148.55 and a 200 day simple moving average of $144.32. The Clorox Company has a 52-week low of $120.50 and a 52-week high of $160.59. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.47 and a current ratio of 0.86. The stock has a market cap of $19.00 billion, a price-to-earnings ratio of 43.94, a PEG ratio of 3.03 and a beta of 0.29.

Clorox (NYSE:CLX – Get Rating) last posted its earnings results on Thursday, February 2nd. The company reported $0.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.66 by $0.32. Clorox had a return on equity of 89.97% and a net margin of 6.16%. The business had revenue of $1.72 billion during the quarter, compared to analysts’ expectations of $1.66 billion. During the same period in the prior year, the business earned $0.66 EPS. Clorox’s revenue for the quarter was up 1.4% compared to the same quarter last year. Analysts anticipate that The Clorox Company will post 4.23 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 12th. Shareholders of record on Wednesday, April 26th will be given a dividend of $1.18 per share. This represents a $4.72 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date is Tuesday, April 25th. Clorox’s dividend payout ratio (DPR) is currently 134.86%.

Analyst Ratings Changes

A number of research analysts have issued reports on CLX shares. Raymond James upped their target price on shares of Clorox from $160.00 to $165.00 and gave the company an “outperform” rating in a research report on Friday, February 3rd. Morgan Stanley upped their price target on Clorox from $142.00 to $145.00 and gave the company an “equal weight” rating in a research note on Friday, February 3rd. Citigroup assumed coverage on Clorox in a research note on Thursday, February 16th. They issued a “neutral” rating and a $155.00 price target for the company. Wells Fargo & Company upped their price target on Clorox from $125.00 to $135.00 and gave the company an “underweight” rating in a research note on Tuesday, January 3rd. Finally, Jefferies Financial Group upped their price target on Clorox from $140.00 to $145.00 and gave the company a “hold” rating in a research note on Wednesday, February 1st. Seven research analysts have rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $141.33.

About Clorox

(Get Rating)

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.